PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 298 (114th)

Medical Testing Availability Act of 2015

referredUnited States· United States Congress· EN

Introduced

13 January 2015

Last action

16 January 2015 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Michael Burgess, Jackie Speier

Subjects

Healthcare

Source updated

12 August 2025

Healthcare

Summary

Medical Testing Availability Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a product labeled for research use only from being deemed adulterated or misbranded on the basis that its manufacturer or distributor: (1) sells the product to an end user who uses the product for a purpose other than research, or (2) engages in business communications with an end user regarding the product.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 13 January 2015

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 13 January 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 13 January 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 16 January 2015

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.